Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix astragali

Basic and Clinical Pharmacology and Toxicology

Volumn 95, Issue 6, 2004, Pages 295-298

  Gu, Yongchuan ^a   Wang, Guangji ^a   Pan, Guoyu ^a   Fawcett, J Paul ^b   A, Jiye ^a   Sun, Jianguo ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRAGALOSIDE IV; ASTRAGALUS RADIX; CHINESE DRUG; GLYCOSIDE; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BILE DUCT LIGATION; CELL STRAIN CACO 2; CHINESE MEDICINE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; INTESTINE PERFUSION; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; BILE DUCTS; BIOLOGICAL AVAILABILITY; CACO-2 CELLS; DRUGS, CHINESE HERBAL; HUMANS; INTESTINAL ABSORPTION; MALE; PERFUSION; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS; TRITERPENES;

ANIMALIA;

EID: 10844291495     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2004.t01-1-pto950508.x     Document Type: Article

References (15)

1. Akao, T., K. Kawabata, E. Yanagisawa, K. Ishihara, Y. Mizuhara, Y. Wakui, Y. Sakashita & K. Kobashi: Balicalin, the predominant flavone glucuronide of Scutellariae Radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J. Pharm. Pharmacol. 2000, 52, 1563-1568.
2. Artursson, P. & J. Karlsson: Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175, 880-885.
3. Bartrakova, E. V., H. Y. Han, V. Y. Alakhov, D. W. Miller & A. V. Kobanov: Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm. Res. 1998, 15, 850-855
4. Conradi, R. A., K. F. Wilkinson, B. D. Rush, A. R. Hilgers, M. J. Ruwart & P. S. Burton: In vitro/in vivo models for peptide oral absorption: Comparison of Caco-2 cell permeability with rat intestinal absorption of renin inhibitory peptides. Pharm. Res. 1993, 10, 1790-1792.
5. Gu, Y.C., G. J. Wang & J. P. Fawcett: Determination of Astragaloside IV in rat plasma by liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B 2004, 801, 285-288.
6. Hilgers, A. R., R. A. Conradi & P. S. Burton: Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm. Res. 1990, 7, 902-910.
7. Ikumi, T., A. Saheki, R. Saitoh, Y. Sai, I. Yamada & A. Tsuji: Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters. J. Pharmacol. Exp. Therap. 1997, 283, 108-115.
8. Kim, D. C., P. S. Burton & R. T. Borchardt: Correlation between the permeability characteristics of a series of peptides using an in vitro cell culture model (Caco-2) and those using an in situ perfused rat ileum model of intestinal mucosa. Pharm. Res. 1993, 10, 1710-1714.
9. 2- antagonists ranitidine and famotidine across Caco-2 cell monolayers. J. Pharm. Sci. 1999, 88, 680-687.
10. Lennernäs, H., K. Palm, U. Fagerholm & P. Artursson: Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int. J. Pharm. 1996, 127, 103-107.
11. Pan, G. Y., G. J. Wang, X. D. Liu, J. P. Fawcett & Y. Y. Xie: The involvement of P-glycoprotein in berberine absorption. Pharmacology & Toxicology 2002, 91, 193-197.
12. Pharmacopoeia of P. R. China (English Edition 2000) Volume I. The State Pharmacopoeial Commission, Chemical Industry Press, Beijing, China. 2000, pp. 161-162.
13. Ren, S. & E. J. Lien: Caco-2 cell permeability vs human gastrointestinal absorption: QSPR analysis. Prog. Drug Res. 2000, 54, 1-23.
14. Rios, J. L. & P. G. Waterman: A review of the pharmacology and toxicology of Astragalus. Phytother. Res. 1997, 11, 411-418.
15. Stewart, B. H., O. H. Chan, N. Jezyk & D. Fleisher: Discrimination between drug candidates using models for evaluation of intestinal absorption. Adv. Drug Deliv. Rev. 1997, 23, 27-45.